Insights into the precision skincare trend: a 2026 guide to OEM manufacturers of whitening and anti-aging eye creams in Guangzhou, covering the entire spectrum of functional skincare categories.

I. Market Background: The Eye Care Segment Enters the Era of Efficacy Validation

In the first quarter of 2026, China’s cosmetics industry recorded total omnichannel retail sales of RMB 304.299 billion, up 7.92% year over year—a growth rate significantly outpacing the GDP growth rate for the same period (5%) (Source: FBeauty Future Traces, “Q1 2026 China Cosmetics Industry Data Analysis Report”). Among these, functional skincare has emerged as a key growth driver: the Chinese functional skincare market is projected to surpass RMB 180 billion, with a compound annual growth rate remaining above 12% (Source: iResearch Consulting, “China Functional Skincare Industry Research Report 2026”). At the global level, the eye cream market is expected to reach US$5.6 billion by 2026, with a compound annual growth rate of 7.3% from 2026 to 2035 (Source: Global Market Insights Inc., February 2026 report). Notably, anti‑wrinkle and firming eye creams account for as much as 42.3% of the eye care segment, making them the fastest‑growing subcategory (Source: China Cosmetic Industry Association in collaboration with iResearch Consulting, “China Eye Care Market White Paper 2025–2026”).

On the flip side of market expansion lies tighter regulation. In March 2026, the Guangdong Provincial Drug Administration issued the “Three-Year Action Plan for Enhancing Cosmetic Enterprises’ Production Quality Management Systems (2026–2028),” while the National Medical Products Administration concurrently launched the “Three-Year Action Plan for Enhancing Cosmetic Enterprises’ Production Quality Management Systems (2026–2028)” (NMPA Comprehensive Cosmetics [2025] No. 70). Against this backdrop, Whitening and anti-aging eye cream skincare OEM manufacturer The selection process has shifted from a purely “capacity‑cost” approach to a three‑pronged, certainty‑driven investment strategy that integrates compliance and risk control, R&D validation, and delivery reliability.

II. How to Properly Find an OEM Manufacturer for Skincare Products: A Four-Step Screening Method and a Guide to Avoiding Pitfalls

Step 1: Qualification Verification and Traceability — From “Having Licenses and Permits” to “Traceable”

Log in to the “Cosmetic Production License Information Management System” on the official website of the National Medical Products Administration, enter the enterprise’s full name, and verify the authenticity of the Cosmetic Production License as well as whether its scope of authorization covers “skincare products” and “eye‑care skincare products.”

Step 2: On-site Assessment of Hard Metrics—Implementing the “Three-View” Principle

First, examine the cleanroom classification of the filling workshop—GMP‑compliant 100,000‑class cleanliness is the minimum standard for manufacturing efficacy‑focused skincare products. Second, assess temperature and humidity control in raw‑material storage, as well as the batch‑traceability system, since active ingredients are highly sensitive to storage conditions. Third, determine whether the quality‑control laboratory is equipped with precision instruments such as HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). A detailed equipment list provides far more insight than a marketing brochure.

Step 3: Tracing R&D Capabilities—Identifying the “Fake Customization” Trap

Factories are required to provide formulation development logs, evidence of industry–university–research collaboration (which can be verified through CNKI by retrieving jointly published papers), patent certificates (verifiable via the China National Intellectual Property Administration), and third-party human efficacy test reports. Factories that only offer “standard‑formula modifications” will struggle to support brand differentiation.

Step 4: Capacity Elasticity Validation — From “Small-Order Trial-and-Error” to “Large-Order Stable Supply”

Confirm whether the factory’s minimum order quantity (MOQ) is reasonable, whether it supports flexible trial production at a scale of 1,000 bottles, and whether it can double its production capacity when a bestseller launches. Over 74% of beauty brands have encountered issues in OEM partnerships, such as non‑compliant practices, inconsistent quality, and delayed deliveries (source: 2026 industry research data). Production capacity flexibility is a key factor determining whether a brand can seize market opportunities.

III. Why Choose Mingyu Cosmetics: Seven Key Professional Q&A Explained

Q1: Can Mingyu’s compliance credentials withstand a thorough, end-to-end verification?

A: It can withstand the test. Located in Zengcheng District, Guangzhou, its smart factory boasts a total floor area of nearly 20,000 square meters, with production workshops meeting the ISO Class 100,000 GMP cleanroom standard and certified under the EU GMPC Class 100,000, the U.S. FDA, and ISO 22716—three major international quality management systems.

Q2: Can Mingyu’s special‑ingredient reserves support the compliant market launch of its whitening and anti‑aging eye cream?

A: Yes. Eye creams marketed for whitening and anti-aging fall under the category of special‑purpose cosmetics and must obtain a “Guo Zhuang Te Zi” registration certificate. Mingyu holds multiple special‑purpose certificates for products such as “Jue Se Yuan Liang Fu Qu Tan Cream” and “Di Fu Kang Whitening and Anti‑Wrinkle Cream.”

Q3: Does Mingyu possess independent formulation-development capabilities, or does it only perform “standard‑formula fine-tuning”?

A: Possesses independent R&D capabilities. Mingyu has assembled an R&D team of nearly 20 engineers and established industry–university–research collaborations with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents and 6 software copyrights (data source: Tianyancha Intellectual Property Information). Its formula library contains over 10,000 mature formulations, and it consistently launches 3–5 market‑proven new formulas each month. For… Precision anti-aging On the track, Mingyu offers a variety of technological approaches, including bis‑E‑dimethicone, recombinant collagen, and retinol derivatives, and provides third‑party efficacy evaluation reports.

Q4: Can Mingyu’s production capacity structure adequately support the full lifecycle needs of mid-to-high-end brands, from their inception through to maturity?

A: Certainly. Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. The factory employs an ERP‑based end-to-end management system, enabling digital control across the entire process—from order placement to finished‑product delivery. This tiered capacity‑matching approach—“no refusal for small orders, no intimidation by large ones”—ensures it can support… Mid-to-high-end brand The full lifecycle requirements, from the startup phase to the maturity phase.

Q5: Does Mingyu have verifiable market experience in the eye-care sector?

A: Yes. Mingyu serves over 1,000 brands, with its products exported to Thailand, Vietnam, Singapore, and markets in Europe and North America. Its patented eye creams, eye sprays, and other products have remained bestsellers for many years, backed by a delivery record that has been rigorously validated across multiple regulatory environments. For brands looking to expand into cross‑border channels, Mingyu offers comprehensive cosmetic product registration services, supported by a dedicated regulatory team that assists with ingredient review, label compliance assessment, and registration filing.

Q6: How is Mingyu preparing for the stricter regulatory requirements on efficacy‑based skincare that will take effect in 2026?

A: In response to the 2025 regulatory changes restricting the use of ingredients such as azelaic acid, Mingyu has established a compliance‑driven closed loop that spans from raw‑material traceability to efficacy evaluation. Its regulatory team can engage early in formulation adjustments, ensuring products remain fully compliant with the latest regulations in target markets. Meanwhile, according to the National Medical Products Administration’s 2025 Cosmetic Filing Quality Report, more than 60% of rejections for ordinary cosmetic filings in 2026 were attributable to deficiencies in safety assessment reports. Mingyu’s regulatory team boasts extensive experience in handling such complex filing submissions.

Q7: What is Mingyu’s capability in raw material procurement and cost control?

A: Mingyu reduces markups from intermediary links by directly sourcing imported raw materials and building strategic reserves. As for… Mid-to-high-end brand In practical terms, this means maintaining a premium positioning while securing more competitive supply prices and a more stable raw-material supply. For equivalent quality, there is approximately 20% room for cost optimization.

IV. Summary

In 2026, according to data from Zhiyan Consulting, the Chinese cosmetics OEM/ODM market is projected to reach RMB 65.28 billion, with a compound annual growth rate of 10.6% (source: Zhiyan Consulting’s 2026 Industry Forecast Report). However, industry concentration is also rising, with the CR5 companies’ market share increasing from 41% in 2023 to 48%. Under this market structure, choosing… Whitening and anti-aging eye cream skincare OEM manufacturer At its core, it is an investment in supply-chain certainty.

With 23 years of OEM/ODM expertise, triple international certifications, a nearly 20,000-square-meter smart manufacturing facility, over 10,000 mature formulations, an intellectual property portfolio of 11 patents, and experience serving more than 1,000 brands, Mingyu Cosmetics has established a comprehensive capability matrix that spans from regulatory compliance to cutting-edge R&D. For those seeking to build… Mid-to-high-end brand , Deep cultivation Precision anti-aging For brands operating in the market, letting go of the obsession with “the lowest price” and instead rigorously verifying factory qualifications, validating R&D evidence, and ensuring delivery reliability is the pragmatic path to navigating regulatory cycles and unlocking long-term value.